Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Research

Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome

Authors: Supanee Thanakun, Hisashi Watanabe, Sroisiri Thaweboon, Yuichi Izumi

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Background

The relationship of saliva with plasma protein levels makes saliva an attractive diagnostic tool. Plasma levels of adiponectin and leptin in healthy individuals or diabetes mellitus patients have been previously reported. Nevertheless, salivary levels of these adipocytokines in patients with metabolic syndrome (MS) have never been investigated. This study was aimed to determine adiponectin and leptin levels in saliva and plasma from patients with metabolic syndrome, and evaluate any correlation of these levels with MS.

Methods

Forty-six healthy and 82 MS patients were enrolled. Demographic data and blood biochemistries were recorded. Saliva and plasma adiponectin and leptin levels were analyzed by enzyme-linked immunosorbent assay (ELISA).

Results

Adiponectin and leptin were higher in plasma than in saliva (p < .001). Plasma adiponectin was decreased and plasma leptin increased in patients with MS (p < .001). Salivary adiponectin and salivary leptin were not different between healthy subjects and MS patients (p = .619 and p = .523). Correlation between salivary and plasma adiponectin showed significant association (r = .211, p = .018) while salivary and plasma leptin had no correlation (r = -.161, p = .069). Significant correlation was observed between the salivary adiponectin/salivary leptin ratio and plasma adiponectin (r = .371, p < .001), but not with any component of MS. Increased triglyceride and waist circumference were associated with risk of having a low level of plasma adiponectin (OR = 1.009; 95% CI 1.002–1.015 and OR = 1.125; 95% CI 1.029–1.230). For leptin, body mass index and high-density lipoprotein cholesterol (HDL-C) were associated with a high level of plasma leptin (OR = 1.621; 95% CI 1.212–2.168 and OR = .966; 95% CI .938–.996). The OR for MS as predicted by plasma adiponectin was .928 (95% CI .881-.977).

Conclusions

This study showed that salivary adiponectin and leptin do not correlate with MS. Although correlation between salivary and plasma adiponectin was observed, no association with MS was observed. Only plasma adiponectin may be useful for the prediction of MS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gavrila D, Salmeron D, Egea-Caparros JM, Huerta JM, Perez-Martinez A, Navarro C, Tormo MJ: Prevalence of metabolic syndrome in murcia region, a Southern European mediterranean area with low cardiovascular risk and high obesity. BMC Public Health. 2011, 11: 562-10.1186/1471-2458-11-562.PubMedCentralCrossRefPubMed Gavrila D, Salmeron D, Egea-Caparros JM, Huerta JM, Perez-Martinez A, Navarro C, Tormo MJ: Prevalence of metabolic syndrome in murcia region, a Southern European mediterranean area with low cardiovascular risk and high obesity. BMC Public Health. 2011, 11: 562-10.1186/1471-2458-11-562.PubMedCentralCrossRefPubMed
2.
go back to reference Gronner M, Bosi P, Carvalho A, Casale G, Contrera D, Pereira M, Diogo T: Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study. Braz J Med Biol Res. 2011, 44: 713-719.PubMed Gronner M, Bosi P, Carvalho A, Casale G, Contrera D, Pereira M, Diogo T: Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study. Braz J Med Biol Res. 2011, 44: 713-719.PubMed
3.
go back to reference Lohsoonthorn V, Lertmaharit S, Williams M: Prevalence of metabolic syndrome among professional and office workers in Bangkok, Thailand. J Med Assoc Thai. 2007, 90: 1908-1915.PubMed Lohsoonthorn V, Lertmaharit S, Williams M: Prevalence of metabolic syndrome among professional and office workers in Bangkok, Thailand. J Med Assoc Thai. 2007, 90: 1908-1915.PubMed
6.
go back to reference Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004, 24: 29-33. 10.1161/01.ATV.0000099786.99623.EF.CrossRefPubMed Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004, 24: 29-33. 10.1161/01.ATV.0000099786.99623.EF.CrossRefPubMed
7.
go back to reference Brooks N, Moore K, Clark R, Perfetti M, Trent C, Combs T: Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?. Diabetes Obes Metab. 2007, 9: 246-258. 10.1111/j.1463-1326.2006.00596.x.CrossRefPubMed Brooks N, Moore K, Clark R, Perfetti M, Trent C, Combs T: Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?. Diabetes Obes Metab. 2007, 9: 246-258. 10.1111/j.1463-1326.2006.00596.x.CrossRefPubMed
8.
go back to reference Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim S-Y, Hamnvik O-PR: Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol. 2011, 301: E567-E584. 10.1152/ajpendo.00315.2011.CrossRef Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim S-Y, Hamnvik O-PR: Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol. 2011, 301: E567-E584. 10.1152/ajpendo.00315.2011.CrossRef
9.
go back to reference Özçelik E, Uslu S, Kebapçı N, Kara M, Dokumacıoğlu A, Musmul A: Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome. Diabetes Metab Syndrome: Clin Res Rev. 2010, 4: 13-17. 10.1016/j.dsx.2010.01.005.CrossRef Özçelik E, Uslu S, Kebapçı N, Kara M, Dokumacıoğlu A, Musmul A: Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome. Diabetes Metab Syndrome: Clin Res Rev. 2010, 4: 13-17. 10.1016/j.dsx.2010.01.005.CrossRef
10.
go back to reference Qasim A, Mehta N, Tadesse M, Wolfe M, Rhodes T, Girman C, Reilly M: Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol. 2008, 52: 231-236. 10.1016/j.jacc.2008.04.016.PubMedCentralCrossRefPubMed Qasim A, Mehta N, Tadesse M, Wolfe M, Rhodes T, Girman C, Reilly M: Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol. 2008, 52: 231-236. 10.1016/j.jacc.2008.04.016.PubMedCentralCrossRefPubMed
11.
go back to reference Schipper R, Silletti E, Vingerhoeds M: Saliva as research material: biochemical, physicochemical and practical aspects. Arch Oral Biol. 2007, 52: 1114-1135. 10.1016/j.archoralbio.2007.06.009.CrossRefPubMed Schipper R, Silletti E, Vingerhoeds M: Saliva as research material: biochemical, physicochemical and practical aspects. Arch Oral Biol. 2007, 52: 1114-1135. 10.1016/j.archoralbio.2007.06.009.CrossRefPubMed
12.
go back to reference Randeva H, Karteris E, Lewandowski K, Sailesh S, O'Hare P, Hillhouse E: Circadian rhythmicity of salivary leptin in healthy subjects. Mol Genet Metab. 2003, 78: 229-235. 10.1016/S1096-7192(03)00004-0.CrossRefPubMed Randeva H, Karteris E, Lewandowski K, Sailesh S, O'Hare P, Hillhouse E: Circadian rhythmicity of salivary leptin in healthy subjects. Mol Genet Metab. 2003, 78: 229-235. 10.1016/S1096-7192(03)00004-0.CrossRefPubMed
13.
go back to reference Toda M, Tsukinoki R, Morimoto K: Measurement of salivary adiponectin levels. Acta Diabetol. 2007, 44: 20-22. 10.1007/s00592-007-0236-8.CrossRefPubMed Toda M, Tsukinoki R, Morimoto K: Measurement of salivary adiponectin levels. Acta Diabetol. 2007, 44: 20-22. 10.1007/s00592-007-0236-8.CrossRefPubMed
14.
go back to reference Jaedicke K: Salivary Adipokine Concentrations in Patients with Type 2 Diabetes. IADR AADR CADR 89th general session and exhibition. 2011, March 16–19 Jaedicke K: Salivary Adipokine Concentrations in Patients with Type 2 Diabetes. IADR AADR CADR 89th general session and exhibition. 2011, March 16–19
15.
go back to reference Thanakun S, Watanabe H, Thaweboon S, Izumi Y: An effective technique for the processing of saliva for the analysis of leptin and adiponectin. Peptides. 2013, 47: 60-65.CrossRefPubMed Thanakun S, Watanabe H, Thaweboon S, Izumi Y: An effective technique for the processing of saliva for the analysis of leptin and adiponectin. Peptides. 2013, 47: 60-65.CrossRefPubMed
16.
go back to reference Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
17.
go back to reference Mamali I, Roupas ND, Armeni AK, Theodoropoulou A, Markou KB, Georgopoulos NA: Measurement of salivary resistin, visfatin and adiponectin levels. Peptides. 2012, 33: 120-124. 10.1016/j.peptides.2011.11.007.CrossRefPubMed Mamali I, Roupas ND, Armeni AK, Theodoropoulou A, Markou KB, Georgopoulos NA: Measurement of salivary resistin, visfatin and adiponectin levels. Peptides. 2012, 33: 120-124. 10.1016/j.peptides.2011.11.007.CrossRefPubMed
18.
go back to reference Akuailou E-N, Vijayagopal P, Imrhan V, Prasad C: Measurement and validation of the nature of salivary adiponectin. Acta Diabetol. 2013, 50: 727-730. 10.1007/s00592-012-0388-z.CrossRefPubMed Akuailou E-N, Vijayagopal P, Imrhan V, Prasad C: Measurement and validation of the nature of salivary adiponectin. Acta Diabetol. 2013, 50: 727-730. 10.1007/s00592-012-0388-z.CrossRefPubMed
20.
go back to reference Fernandez-Botran R, Miller JJ, Burns VE, Newton TL: Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence. Brain Behav Immun. 2011, 25: 314-321. 10.1016/j.bbi.2010.09.023.PubMedCentralCrossRefPubMed Fernandez-Botran R, Miller JJ, Burns VE, Newton TL: Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence. Brain Behav Immun. 2011, 25: 314-321. 10.1016/j.bbi.2010.09.023.PubMedCentralCrossRefPubMed
21.
go back to reference Aydin S, Halifeoglu I, Ozercan I, Erman F, Kilic N, Ilhan N, Ozkan Y, Akpolat N, Sert L, Caylak E: A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Peptides. 2005, 26: 647-652. 10.1016/j.peptides.2004.11.008.CrossRefPubMed Aydin S, Halifeoglu I, Ozercan I, Erman F, Kilic N, Ilhan N, Ozkan Y, Akpolat N, Sert L, Caylak E: A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Peptides. 2005, 26: 647-652. 10.1016/j.peptides.2004.11.008.CrossRefPubMed
22.
go back to reference Gröschl M, Rauh M, Wagner R, Neuhuber W, Metzler M, Tamgüney G, Zenk J, Schoof E, Dörr HG, Blum WF, et al: Identification of leptin in human saliva. J Clin Endocrinol Metab. 2001, 86: 5234-5239. 10.1210/jcem.86.11.7998.CrossRefPubMed Gröschl M, Rauh M, Wagner R, Neuhuber W, Metzler M, Tamgüney G, Zenk J, Schoof E, Dörr HG, Blum WF, et al: Identification of leptin in human saliva. J Clin Endocrinol Metab. 2001, 86: 5234-5239. 10.1210/jcem.86.11.7998.CrossRefPubMed
23.
go back to reference Schapher M, Wendler O, Gröschl M, Schäfer R, Iro H, Zenk J: Salivary leptin as a candidate diagnostic marker in salivary gland tumors. Clin Chem. 2009, 55: 914-922. 10.1373/clinchem.2008.116939.CrossRefPubMed Schapher M, Wendler O, Gröschl M, Schäfer R, Iro H, Zenk J: Salivary leptin as a candidate diagnostic marker in salivary gland tumors. Clin Chem. 2009, 55: 914-922. 10.1373/clinchem.2008.116939.CrossRefPubMed
24.
go back to reference King GA, Deemer SE, Thompson DL: Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol. 2012, 49 (Suppl 1): S41-S49.CrossRefPubMed King GA, Deemer SE, Thompson DL: Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol. 2012, 49 (Suppl 1): S41-S49.CrossRefPubMed
25.
go back to reference Kim J-Y, Ahn SV, Yoon J-H, Koh S-B, Yoon J, Yoo B-S, Lee S-H, Park J-K, Choe K-H, Guallar E: Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care. 2013, 36: 1547-1553. 10.2337/dc12-0223.PubMedCentralCrossRefPubMed Kim J-Y, Ahn SV, Yoon J-H, Koh S-B, Yoon J, Yoo B-S, Lee S-H, Park J-K, Choe K-H, Guallar E: Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care. 2013, 36: 1547-1553. 10.2337/dc12-0223.PubMedCentralCrossRefPubMed
26.
go back to reference Kim DH, Kim C, Ding EL, Townsend MK, Lipsitz LA: Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Hypertension. 2013, 62: 27-32. 10.1161/HYPERTENSIONAHA.113.01453.PubMedCentralCrossRefPubMed Kim DH, Kim C, Ding EL, Townsend MK, Lipsitz LA: Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Hypertension. 2013, 62: 27-32. 10.1161/HYPERTENSIONAHA.113.01453.PubMedCentralCrossRefPubMed
27.
go back to reference Chiu F-H, Chuang CH, Li W-C, Weng Y-M, Fann W-C, Lo H-Y, Sun C, Wang S-H: The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults. Cardiovasc Diabetol. 2012, 11: 40-10.1186/1475-2840-11-40.PubMedCentralCrossRefPubMed Chiu F-H, Chuang CH, Li W-C, Weng Y-M, Fann W-C, Lo H-Y, Sun C, Wang S-H: The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults. Cardiovasc Diabetol. 2012, 11: 40-10.1186/1475-2840-11-40.PubMedCentralCrossRefPubMed
28.
go back to reference Wannamethee SG, Tchernova J, Whincup P, Lowe GDO, Kelly A, Rumley A, Wallace AM, Sattar N: Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. 2007, 191: 418-426.CrossRefPubMed Wannamethee SG, Tchernova J, Whincup P, Lowe GDO, Kelly A, Rumley A, Wallace AM, Sattar N: Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. 2007, 191: 418-426.CrossRefPubMed
29.
go back to reference Wang Z, Zhuo Q, Fu P, Piao J, Tian Y, Xu J, Yang X: Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults?. Diabetes/Metab Res. 2010, 26: 109-114. 10.1002/dmrr.1060.CrossRef Wang Z, Zhuo Q, Fu P, Piao J, Tian Y, Xu J, Yang X: Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults?. Diabetes/Metab Res. 2010, 26: 109-114. 10.1002/dmrr.1060.CrossRef
30.
go back to reference Vega GL, Grundy SM: Metabolic risk susceptibility in Men is partially related to adiponectin/leptin ratio. J Obes. 2013, 2013: 9-CrossRef Vega GL, Grundy SM: Metabolic risk susceptibility in Men is partially related to adiponectin/leptin ratio. J Obes. 2013, 2013: 9-CrossRef
31.
go back to reference Izadi V, Farabad E, Azadbakht L: Epidemiologic evidence on serum adiponectin level and lipid profile. Int J Of Preventive Med. 2013, 4: 133-140. Izadi V, Farabad E, Azadbakht L: Epidemiologic evidence on serum adiponectin level and lipid profile. Int J Of Preventive Med. 2013, 4: 133-140.
32.
go back to reference Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh T, Ohtsuka N: Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis. 2011, 10: 79-10.1186/1476-511X-10-79.PubMedCentralCrossRefPubMed Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh T, Ohtsuka N: Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis. 2011, 10: 79-10.1186/1476-511X-10-79.PubMedCentralCrossRefPubMed
33.
go back to reference Mojiminiyi O, Abdella N, Arouj M, Nakhi A: Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Inter J Obes. 2007, 31: 213-220. 10.1038/sj.ijo.0803355.CrossRef Mojiminiyi O, Abdella N, Arouj M, Nakhi A: Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Inter J Obes. 2007, 31: 213-220. 10.1038/sj.ijo.0803355.CrossRef
34.
go back to reference Kim SY, Lee SJ, Park HK, Yun JE, Lee M, Sung J, Jee SH: Adiponectin is associated with impaired fasting glucose in the Non-diabetic population. Epidemiol and Health. 2011, 33: e2011007-CrossRef Kim SY, Lee SJ, Park HK, Yun JE, Lee M, Sung J, Jee SH: Adiponectin is associated with impaired fasting glucose in the Non-diabetic population. Epidemiol and Health. 2011, 33: e2011007-CrossRef
35.
go back to reference Alexander CM, Landsman PB, Grundy SM: The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab. 2008, 10: 246-250. 10.1111/j.1463-1326.2006.00695.x.CrossRefPubMed Alexander CM, Landsman PB, Grundy SM: The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab. 2008, 10: 246-250. 10.1111/j.1463-1326.2006.00695.x.CrossRefPubMed
36.
go back to reference Worachartcheewan A, Nantasenamat C, Isarankura-Na-Ayudhya C, Pidetcha P, Prachayasittikul V: Lower BMI cutoff for assessing the prevalence of metabolic syndrome in Thai population. Acta Diabetol. 2010, 47: 91-96. 10.1007/s00592-009-0137-0.CrossRefPubMed Worachartcheewan A, Nantasenamat C, Isarankura-Na-Ayudhya C, Pidetcha P, Prachayasittikul V: Lower BMI cutoff for assessing the prevalence of metabolic syndrome in Thai population. Acta Diabetol. 2010, 47: 91-96. 10.1007/s00592-009-0137-0.CrossRefPubMed
37.
go back to reference Schutte AE, Huisman HW, Schutte R, van Rooyen JM, Malan L, Fourie CMT, Malan NT: Adipokines and cardiometabolic function: How are they interlinked?. Regul Pept. 2010, 164: 133-138. 10.1016/j.regpep.2010.06.008.CrossRefPubMed Schutte AE, Huisman HW, Schutte R, van Rooyen JM, Malan L, Fourie CMT, Malan NT: Adipokines and cardiometabolic function: How are they interlinked?. Regul Pept. 2010, 164: 133-138. 10.1016/j.regpep.2010.06.008.CrossRefPubMed
38.
go back to reference Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, et al: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002, 51: 2734-2741. 10.2337/diabetes.51.9.2734.CrossRefPubMed Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, et al: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002, 51: 2734-2741. 10.2337/diabetes.51.9.2734.CrossRefPubMed
39.
go back to reference Webb DR, Khunti K, Chatterjee S, Jarvis J, Davies MJ: Adipocytokine associations with insulin resistance in british South Asians. Exp Diabetes Res. 2013, 2013: 7- Webb DR, Khunti K, Chatterjee S, Jarvis J, Davies MJ: Adipocytokine associations with insulin resistance in british South Asians. Exp Diabetes Res. 2013, 2013: 7-
40.
go back to reference Al-Daghri NM, Al-Attas OS, Sallam R: Adipocytokine profiles as influenced by insulin resistance in obese subjects. Diabetes & Metab Syndr: Clin Res & Rev. 2009, 3: 79-83. 10.1016/j.dsx.2009.02.004.CrossRef Al-Daghri NM, Al-Attas OS, Sallam R: Adipocytokine profiles as influenced by insulin resistance in obese subjects. Diabetes & Metab Syndr: Clin Res & Rev. 2009, 3: 79-83. 10.1016/j.dsx.2009.02.004.CrossRef
41.
go back to reference Li S, Shin H, Ding E, RM vD: Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009, 302: 179-188. 10.1001/jama.2009.976.CrossRefPubMed Li S, Shin H, Ding E, RM vD: Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009, 302: 179-188. 10.1001/jama.2009.976.CrossRefPubMed
42.
go back to reference Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M: Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab Syndr and Relat Disord. 2009, 7: 447-452. 10.1089/met.2008.0100.CrossRef Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M: Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab Syndr and Relat Disord. 2009, 7: 447-452. 10.1089/met.2008.0100.CrossRef
43.
go back to reference Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N: Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest. 2011, 34: 615-619.PubMed Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N: Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest. 2011, 34: 615-619.PubMed
Metadata
Title
Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
Authors
Supanee Thanakun
Hisashi Watanabe
Sroisiri Thaweboon
Yuichi Izumi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-19

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.